Vitamin D Deficiency Is Not Associated with Diabetic Retinopathy or Maculopathy

Journal of Diabetes Research

Volumn 2016, Issue , 2016, Pages

  Alam, Uazman ^a   Amjad, Yasar ^a   Chan, Anges Wan Shan ^b   Asghar, Omar ^a   Petropoulos, Ioannis N ^b   Malik, Rayaz A ^a,c  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c WEILL CORNELL MEDICAL COLLEGE   (Qatar)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; 25-HYDROXYVITAMIN D; VITAMIN D;

ADULT; ARTICLE; CROSS-SECTIONAL STUDY; DIABETIC PATIENT; DIABETIC RETINOPATHY; DISEASE SEVERITY ASSESSMENT; FEMALE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RETINA MACULOPATHY; RETROSPECTIVE STUDY; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; AGED; ANALOGS AND DERIVATIVES; ANTHROPOMETRY; BLOOD; BLOOD PRESSURE; COMPLICATION; MACULAR DEGENERATION; MIDDLE AGED; REGRESSION ANALYSIS;

ADULT; AGED; ANTHROPOMETRY; BLOOD PRESSURE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; HUMANS; MACULAR DEGENERATION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84961812228     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2016/6156217     Document Type: Article

References (32)

1. J. W. Y. Yau, S. L. Rogers, R. Kawasaki et al., "Global prevalence and major risk factors of diabetic retinopathy, " Diabetes Care, vol. 35, no. 3, pp. 556-564, 2012.
2. C. Bunce and R. Wormald, "Leading causes of certification for blindness and partial sight in England & Wales, " BMC Public Health, vol. 6, article 58, 2006.
3. S. Resnikoff, D. Pascolini, D. Etya'ale et al., "Global data on visual impairment in the year 2002, " Bulletin of theWorldHealth Organization, vol. 82, no. 11, pp. 844-851, 2004.
4. C. Joergensen, P. Hovind, A. Schmedes, H.-H. Parving, and P. Rossing, "Vitamin D levels, microvascular complications, and mortality in type 1 diabetes, " Diabetes Care, vol. 34, no. 5, pp. 1081-1085, 2011.
5. F. Ismail-Beigi, T. Craven, M. A. Banerji et al., "Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: An analysis of the ACCORD randomised trial, " The Lancet, vol. 376, no. 9739, pp. 419-430, 2010.
6. F. Ismail-Beigi, T. E. Craven, P. J. O'Connor et al., "Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients, " Kidney International, vol. 81, no. 6, pp. 586-594, 2012.
7. H.-P. Hammes, Y. Feng, F. Pfister, and M. Brownlee, "Diabetic retinopathy: Targeting vasoregression, " Diabetes, vol. 60, no. 1, pp. 9-16, 2011.
8. C.-T. C. Lee, E. L. Gayton, J. W. J. Beulens, D. W. Flanagan, and A. I. Adler, "Micronutrients and diabetic retinopathy a systematic review, " Ophthalmology, vol. 117, no. 1, pp. 71-78, 2010.
9. M. F. Holick, "Medical progress: vitamin D deficiency, " The New England Journal of Medicine, vol. 357, no. 3, pp. 266-281, 2007.
10. T. J. Wang, M. J. Pencina, S. L. Booth et al., "Vitamin D deficiency and risk of cardiovascular disease, " Circulation, vol. 117, no. 4, pp. 503-511, 2008.
11. K. Bućan, M. Ivanisevíc, T. Zemunik et al., "Retinopathy and nephropathy in type 1 diabetic patients-association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and Il-1 receptor 1 genes, " Collegium Antropologicum, vol. 33, supplement 2, pp. 99-105, 2009.
12. M. J. Taverna, J.-L. Selam, and G. Slama, "Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptidenegative type 1 diabetes, " Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 8, pp. 4803-4808, 2005.
13. M. J. Taverna, A. Sola, C. Guyot-Argenton et al., "Taq I polymorphism of the vitamin D receptor and risk of severe diabetic retinopathy, " Diabetologia, vol. 45, no. 3, pp. 436-442, 2002.
14. A. Verstappen, M. Parmentier, M. Chirnoaga, D. E. Lawson, J. L. Pasteels, and R. Pochet, "Vitamin D-dependent calcium binding protein immunoreactivity in human retina, " Ophthalmic Research, vol. 18, no. 4, pp. 209-214, 1986.
15. T. A. Craig, S. Sommer, C. R. Sussman, J. P. Grande, and R. Kumar, "Expression and regulation of the vitamin D receptor in the zebrafish, Danio rerio, " Journal of Bone and Mineral Research, vol. 23, no. 9, pp. 1486-1496, 2008.
16. N. Wagner, K.-D. Wagner, G. Schley, L. Badiali, H. Theres, and H. Scholz, "1, 25-Dihydroxyvitamin D3-induced apoptosis of retinoblastoma cells is associated with reciprocal changes of Bcl-2 and bax, " Experimental Eye Research, vol. 77, no. 1, pp. 1-9, 2003.
17. A. Cardus, S. Panizo, M. Encinas et al., "1, 25-Dihydroxyvitamin D3 regulates VEGF production through a vitamin D response element in the VEGF promoter, " Atherosclerosis, vol. 204, no. 1, pp. 85-89, 2009.
18. N. Panou, S. Georgopoulos, T. N. Sergentanis, A. Papalampros, M. Maropoulos, and N. Tentolouris, "Serum 25(OH)D and VEGF in diabetes mellitus type 2: gender-specific associations, " International Journal of Collaborative Research on Internal Medicine & Public Health, vol. 3, pp. 790-795, 2011.
19. D. M. Albert, E. A. Scheef, S. Wang et al., "Calcitriol is a potent inhibitor of retinal neovascularization, " Investigative Ophthalmology & Visual Science, vol. 48, no. 5, pp. 2327-2334, 2007.
20. O. Kordonouri, A. Wladimirowa, and T. Danne, "High total serum renin concentrations are associated with the development of background retinopathy in adolescents with type 1 diabetes, " Diabetes Care, vol. 23, no. 7, pp. 1025-1026, 2000.
21. T. Harindhanavudhi, M. Mauer, R. Klein, B. Zinman, A. Sinaiko, and M. L. Caramori, "Benefits of renin-angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control, " Diabetes Care, vol. 34, no. 8, pp. 1838-1842, 2011.
22. R. Ireland, "Diabetic nephropathy: paricalcitol lowers residual albuminuria in type 2 diabetes, " Nature ReviewsNephrology, vol. 7, article 62, 2011.
23. H. Aksoy, F. Akçay, N. Kurtul, O. Baykal, and B. Avci, "Serum 1, 25 dihydroxy vitamin D (1, 25(OH)2D3), 25 hydroxy vitamin D(25(OH)D) and parathormone levels in diabetic retinopathy, " Clinical Biochemistry, vol. 33, no. 1, pp. 47-51, 2000.
24. H. Kaur, K. C. Donaghue, A. K. Chan et al., "Vitamin D deficiency is associated with retinopathy in children and adolescents with type 1 diabetes, " Diabetes Care, vol. 34, no. 6, pp. 1400-1402, 2011.
25. J. F. Payne, R. Ray, D. G. Watson et al., "Vitamin D insufficiency in diabetic retinopathy, " Endocrine Practice, vol. 18, no. 2, pp. 185-193, 2012.
26. P. A. Patrick, P. F. Visintainer, Q. Shi, I. A. Weiss, and D. A. Brand, "Vitamin D and retinopathy in adults with diabetes mellitus, " Archives of Ophthalmology, vol. 130, no. 6, pp. 756-760, 2012.
27. P. H. Scanlon, "The English national screening programme for sight-threatening diabetic retinopathy, " Journal of Medical Screening, vol. 15, no. 1, pp. 1-4, 2008.
28. S. Patra, E. M. W. Gomm, M. Macipe, and C. Bailey, "Interobserver agreement between primary graders and an expert grader in the Bristol andWeston diabetic retinopathy screening programme: A quality assurance audit, " Diabetic Medicine, vol. 26, no. 8, pp. 820-823, 2009.
29. U. Alam, O. Najam, S. Al-Himdani et al., "Marked vitamin D deficiency in patients with diabetes in the UK: ethnic and seasonal differences and an association with dyslipidaemia, " Diabetic Medicine, vol. 29, no. 10, pp. 1343-1345, 2012.
30. H. F. Deluca andM. T. Cantorna, "VitaminD: its role and uses in immunology, " The FASEB Journal, vol. 15, no. 14, pp. 2579-2585, 2001.
31. G. Zoppini, A. Galletti, G. Targher et al., "Lower levels of 25-hydroxyvitamin D3 are associated with a higher prevalence of microvascular complications in patients with type 2 diabetes, " BMJ Open Diabetes Research & Care, vol. 3, no. 1, Article ID e000058, 2015.
32. L. Engelen, C. G. Schalkwijk, S. J. Eussen et al., "Low 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3 levels are independently associated withmacroalbuminuria, but not with retinopathy and macrovascular disease in type 1 diabetes: The EURODIAB prospective complications study, " Cardiovascular Diabetology, vol. 14, article 67, 2015.